These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20829589)

  • 1. Probiotics and obesity.
    Blaut M; Bischoff SC
    Ann Nutr Metab; 2010; 57 Suppl():20-3. PubMed ID: 20829589
    [No Abstract]   [Full Text] [Related]  

  • 2. Probiotics: Interaction with gut microbiome and antiobesity potential.
    Arora T; Singh S; Sharma RK
    Nutrition; 2013 Apr; 29(4):591-6. PubMed ID: 23287068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotic therapy for celiac disease.
    Tavakkoli A; Green PH
    J Clin Gastroenterol; 2013 Feb; 47(2):101-3. PubMed ID: 23314665
    [No Abstract]   [Full Text] [Related]  

  • 4. Existing knowledge of the human gut microbiota.
    Macfarlane G
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46 Suppl 1():E10. PubMed ID: 18354313
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity.
    Kondo S; Xiao JZ; Satoh T; Odamaki T; Takahashi S; Sugahara H; Yaeshima T; Iwatsuki K; Kamei A; Abe K
    Biosci Biotechnol Biochem; 2010; 74(8):1656-61. PubMed ID: 20699581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of necrotizing enterocolitis with probiotics.
    Kliegman RM; Willoughby RE
    Pediatrics; 2005 Jan; 115(1):171-2. PubMed ID: 15629995
    [No Abstract]   [Full Text] [Related]  

  • 7. Probiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseases.
    Strowski MZ; Wiedenmann B
    Gut; 2009 Aug; 58(8):1044-5. PubMed ID: 19592687
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intestinal flora, responsible for our body weight and an inflammation].
    Golay A; Giusti V
    Rev Med Suisse; 2009 Mar; 5(196):659. PubMed ID: 19462607
    [No Abstract]   [Full Text] [Related]  

  • 9. Bifidobacterium bifidum MIMBb75 in irritable bowel syndrome.
    Quigley EM
    Aliment Pharmacol Ther; 2011 Jul; 34(1):100-1; author reply 101. PubMed ID: 21631550
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes of intestinal microecology during early infancy and subsequent risk of obesity].
    Li F; Zhang L
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):506-9. PubMed ID: 25224055
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of Lactobacillus acidophilus NCDC 13 supplementation on the progression of obesity in diet-induced obese mice.
    Arora T; Anastasovska J; Gibson G; Tuohy K; Sharma RK; Bell J; Frost G
    Br J Nutr; 2012 Oct; 108(8):1382-9. PubMed ID: 22289627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal colonisation, microbiota and future probiotics?
    Salminen S; Benno Y; de Vos W
    Asia Pac J Clin Nutr; 2006; 15(4):558-62. PubMed ID: 17077076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics and obesity: a link?
    Raoult D
    Nat Rev Microbiol; 2009 Sep; 7(9):616. PubMed ID: 21548178
    [No Abstract]   [Full Text] [Related]  

  • 14. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.
    Ringel Y; Ringel-Kulka T
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S145-8. PubMed ID: 21992954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health, probiotics, and inflammation.
    Mengheri E
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S177-8. PubMed ID: 18685508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of the development of the intestinal microbiota in infancy.
    Vael C; Desager K
    Curr Opin Pediatr; 2009 Dec; 21(6):794-800. PubMed ID: 19770768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics-containing yogurts suppress Helicobacter pylori load and modify immune response and intestinal microbiota in the Helicobacter pylori-infected children.
    Yang YJ; Sheu BS
    Helicobacter; 2012 Aug; 17(4):297-304. PubMed ID: 22759330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arabinoxylan oligosaccharides with different structures exert a bifidogenic effect in a mixed intestinal community.
    Grootaert C; Verstraete W; Van de Wiele T
    Commun Agric Appl Biol Sci; 2006; 71(1):159-63. PubMed ID: 17191497
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral Bifidobacterium modulates intestinal immune inflammation in mice with food allergy.
    Zhang LL; Chen X; Zheng PY; Luo Y; Lu GF; Liu ZQ; Huang H; Yang PC
    J Gastroenterol Hepatol; 2010 May; 25(5):928-34. PubMed ID: 20546446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics and intestinal inflammatory disorders in infants and children.
    Vanderhoof JA
    J Pediatr Gastroenterol Nutr; 2000; 30 Suppl 2():S34-8. PubMed ID: 10749399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.